Decheng Capital

Funding rounds backed by Decheng Capital.

Export CSV
Funding disclosed in full
$200M
Median round
$100M
Rounds in calculation
2
2 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Vivacta Biotechnology

Develops in vivo CAR-T cell therapies for cancer and autoimmune diseases

$50MSeries A+BiotechChina
9 participantsApricot CapitalBeijing ShunxiC&D Emerging Industry Equity InvestmentDecheng CapitalEisai Innovation Inc.HanKang CapitalLoyal Valley CapitalOrbiMedQiming Venture Partners
Syneron Bio

Develops intelligent platform-driven macrocyclic peptide drug discovery

$150MSeries BBiotechChina
13 participants5Y CapitalAbu Dhabi Investment AuthorityAstraZenecaBiotech Development FundBioTrack CapitalCDH VGCDecheng CapitalGL VenturesLAVLenovo CapitalQiming Venture PartnersSinovation CapitalTrue Light Capital